Feng Chi Biotech (ROCO:6744) Forward Dividend Yield %: 5.53% (As of Jul. 01, 2026)


ROCO:6744 Feng Chi Biotech Corp ROCO:6744
82 GF Score
Price NT$15.10
GF Value NT$20.85
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Feng Chi Biotech Forward Dividend Yield %?

Feng Chi Biotech ROCO:6744 -0.66% 82 Forward Dividend Yield % is 5.53% as of Jul. 01, 2026. GuruFocus rates ROCO:6744 with a GF Score™ of 82/100 and a GF Value™ of NT$20.85 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 147 Biotechnology companies, Feng Chi Biotech ranks better than 86.39% on this metric.

As of today (2026-07-01), the Forward Annual Dividend Yield of Feng Chi Biotech is 5.53%.

As of today (2026-07-01), the Trailing Annual Dividend Yield of Feng Chi Biotech is 6.25%.

ROCO:6744's Forward Dividend Yield % is ranked better than
86.39% of 147 companies
in the Biotechnology industry
Industry Median: 1.45 vs ROCO:6744: 5.53

Feng Chi Biotech's Dividends per Share for the six months ended in Dec. 2025 was NT$0.95.

During the past 12 months, Feng Chi Biotech's average Dividends Per Share Growth Rate was -9.50% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -8.70% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 0.20% per year.

During the past 10 years, the highest 3-Year average Dividends Per Share Growth Rate of Feng Chi Biotech was 14.50% per year. The lowest was -8.70% per year. And the median was -3.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Feng Chi Biotech  (ROCO:6744) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Feng Chi Biotech Forward Dividend Yield % Related Terms


ROCO:6744 vs VRTX, REGN, ALNY: Forward Dividend Yield % Comparison

For the Biotechnology subindustry, Feng Chi Biotech's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech Forward Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's Forward Dividend Yield % falls into.


ROCO:6744
82GF Score
Feng Chi Biotech Corp ROCO:6744
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Feng Chi Biotech Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Feng Chi Biotech Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
TWD 0.9500002025-07-222025-07-232025-08-11Cash DividendannuallyTWD:TWD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Feng Chi Biotech's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.95/15.10
=6.29 %

Current Share Price is NT$15.10.
Feng Chi Biotech's Dividends per Share for the forward twelve months is calculated as NT$0.95 * 1 = NT$0.95.

Feng Chi Biotech's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.95/15.10
=6.29 %

Current Share Price is NT$15.10.
Feng Chi Biotech's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$0.95.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 5.53% mean?
Feng Chi Biotech (ROCO:6744) has a Forward Dividend Yield % of 5.53% as of Jul. 01, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Feng Chi Biotech and its competitors. According to the industry distribution chart, Feng Chi Biotech ranks #20 out of 147 companies in the Biotechnology industry, placing it in the top 13.6%.
Is Feng Chi Biotech's Forward Dividend Yield % too high?
Feng Chi Biotech's current Forward Dividend Yield % is 5.53%. The Biotechnology industry median Forward Dividend Yield % is 1.45. Feng Chi Biotech's value of 5.53% is 281.4% above this industry median. Based on the distribution chart, Feng Chi Biotech ranks #20 out of 147 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Feng Chi Biotech has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Feng Chi Biotech's Forward Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Feng Chi Biotech ranks #20 out of 147 companies for Forward Dividend Yield %. This places Feng Chi Biotech in the top 14% of its industry — outperforming the majority of peers. The industry median Forward Dividend Yield % is 1.45. Feng Chi Biotech's value of 5.53% is 281.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.45, based on 147 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Feng Chi Biotech's current Forward Dividend Yield % of 5.53% is 281.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Feng Chi Biotech and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feng Chi Biotech's current Forward Dividend Yield % is 5.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feng Chi Biotech stock overvalued right now?
Based on GuruFocus' analysis, Feng Chi Biotech (ROCO:6744) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$20.85, compared to a current price of NT$15.10 — trading 27.6% below its estimated fair value. The current Forward Dividend Yield % is 5.53% and 281.4% above the Biotechnology industry median of 1.45. Feng Chi Biotech's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Feng Chi Biotech (ROCO:6744), the current Forward Dividend Yield % is 5.53% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Feng Chi Biotech (ROCO:6744) Overvalued in 2026?

Based on GuruFocus' analysis, Feng Chi Biotech stock appears to be undervalued. The current stock price of NT$15.10 is trading 27.6% below its estimated GF Value™ of NT$20.85. GuruFocus considers Feng Chi Biotech to be Modestly Undervalued.

Key valuation signals for ROCO:6744:

  • Forward Dividend Yield %: 5.53%
  • GF Value™: NT$20.85 vs. price of NT$15.10 (27.6% below fair value)
  • GF Score™: 82/100 with 4 warning signs
  • Industry Position: 281.4% above the Biotechnology median (#20 of 147)

No single metric tells the full story. See the ROCO:6744 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Feng Chi Biotech Business Description

Address No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.
82GF Score

Get the complete analysis for ROCO:6744

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$15.10
Price
NT$20.85
GF Value